Heat Biologics, Inc.
COMBINATION CELL-BASED THERAPIES
Last updated:
Abstract:
The present disclosure provides methods of treatment with cells having a vaccine (e.g., gp96-Ig) and cells having a T-cell co-stimulatory molecule.
Status:
Application
Type:
Utility
Filling date:
1 Oct 2019
Issue date:
11 Nov 2021